Pharmacology of Traditional Herbal Medicines and Their Active Principles Used in the Treatment of Peptic Ulcer, Diarrhoea and Inflammatory Bowel Disease by Bhavani Prasad Kota et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
14 
Pharmacology of Traditional Herbal  
Medicines and Their Active Principles  
Used in the Treatment of Peptic Ulcer,  
Diarrhoea and Inflammatory Bowel Disease 
Bhavani Prasad Kota1, Aik Wei Teoh2 and Basil D. Roufogalis1 
1University of Sydney 
2Ferngrove Pharmaceuticals 
Australia 
1. Introduction 
The endocrine, exocrine and paracrine secretions of the gastrointestinal (GI) tract play a 
pivotal role in the digestion and absorption of food and orally administered drugs. The 
secretion of mucus by mucus-secreting cells protects the erosion of the gastric mucosa from 
the highly acidic gastric juice. The secretion of hydrochloric acid from parietal cells is 
regulated by acetylcholine, histamine and gastrin. Disturbances in secretory functions of the 
gastrointestinal tract can lead to several GI complications. Conventional therapies employ a 
range of drugs that have been pharmacologically well characterised. While these drug 
molecules are proven to be beneficial, the adverse effects and drug-drug interactions 
highlight the need for better treatment modalities for GI tract disorders. 
Since ancient times, herbal medicines have been traditionally used to treat several diseases. 
The gastroprotective properties of these herbs and their active constituents have been 
experimentally demonstrated (Al Mofleh, 2010). Asian traditional medicine systems have 
identified several herbs and spices to treat GI tract disorders (Langmead & Rampton, 2006; 
Sengupta et al., 2004). In support of these traditional claims, several preclinical and clinical 
studies have provided the scientific basis for the effectiveness of herbal extracts (e.g. 
Glycyrrhiza glabra) and their active constituents (e.g. flavonoids) in treating GI tract disorders 
(Borrelli & Izzo, 2000). The discovery and development of anti-ulcer agents such as 
carbenoxolone from Glycyrrhiza glabra and gefarnate from cabbage further highlight the 
presence of pharmacologically active components in herbal extracts and suggests their use 
as an alternative therapy to treat GI tract disorders. 
The effectiveness and the mechanisms of action of crude herbal extracts vary according the 
composition of their chemical constituents. Herbal medicine seems to fill this gap, especially 
when employing high manufacturing standardised forms of herbal medicine with regard to 
the quality and quantity of ingredients (Suzuki et al., 2009). In addition, well characterised 
herbal formulations may lead to the production of reliable clinical data on efficacy and safety. 
As several studies have shown that herbal medicines may produce adverse reactions and herb-
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drug interactions, the common assumption that ‘herbal products are natural, they are safe’ is 
no longer valid. Safety and quality data of herbal medicines should be made available to 
medical practitioners and other healthcare professionals to avoid these unwanted effects. 
Several plants have been used by traditional healers around the world to treat various 
gastrointestinal tract diseases. Centuries ago the reliance on nature to cure human ailments 
was developed by great efforts of dedicated professionals by keen observation and trial and 
error method. This important knowledge is updated constantly and passed from 
generations to generations. Today traditional healing systems play important roles in 
several parts of the world, especially where modern pharmaceuticals are less accessible. 
Modern scientific research methods are invaluable to support traditional claims and also to 
develop traditional remedies as a viable alternative to mainstream pharmaceuticals. In 
recent years, a number of research papers have been published on herbal medicines to 
provide the experimental evidence for their traditional claims. Given the multitude of these 
research publications, it is not possible to cover all of them. In this chapter, we only 
attempted to provide the experimental (animal and human studies) evidence for the plants 
that have been traditionally used to treat most notable gastrointestinal diseases, namely, 
peptic ulcer, diarrhoea and inflammatory bowel syndrome. 
2. Peptic ulcer 
2.1 Animal models of gastric ulcer 
Rats are commonly used animals to induce ulcers that resemble the human condition by 
various noxious chemical agents. NSAIDs (eg. Indomethacin and Aspirin) cause 
gastrointestinal ulceration, due to their ability to suppress cytoprotective prostaglandin 
synthesis (Wallace, 2001). The NSAIDS-induced ulcer model is important to identify 
mechanisms of action of plants that maintain the gastric mucosa integrity by balancing the 
toxic effects of NSAIDs. The widely used ethanol-induced gastric ulcer model is suitable to 
study gastric protective and free radical scavenging properties of plants. Stress induced 
gastric lesions in rats are useful to study gastric mucosal barrier strengthening properties 
(eg. increased mucus production) of potential plant extracts and their actives. Pylorus 
ligation in rats helps to screen plants for their antisecretory properties. 
2.2 Plants used in the treatment of peptic ulcer 
 Diodia sarmentosa (Rubiaceae), Cassia nigricans (Celsapinaceae), Ficus exasperate 
(Moraceae) and Synclisia scabrida (Menispermaceae) are the most popularly used 
antiulcer recipes in Nigeria. In vivo studies in mice and rats revealed their anti-ulcer 
activities by decreasing the ulcer index in aspirin-induced ulcerogenesis, delayed 
intestinal transit, increased pH, and decreased volume and acidity of gastric secretion 
(Akah et al., 1998).  
 Eruca sativa, commonly known as Rocket, is a commonly used leaf vegetable in Unani, 
Ayurveda and Arab traditional medicine systems. Rocket is shown to possess 
significant anti-secretory, anti-ulcer and cytoprotective properties in rats (Alqasoumi et 
al., 2009). Pretreatment with ethanolic extract of Rocket attenuated gastric ulceration 
induced by ethanol, indomethacin and hypothermic stress. In pylorus ligated rats, 
Rocket dose-dependently reduced gastric acid secretion. In addition, the extract 
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significantly replenished gut wall mucous and reduced malondialdehyde (an indicator 
of lipid peroxidation) levels in ethanol treated rats. Gastroprotective effects of Rocket 
are attributed to the presence of flavonoids, sterols and triterpines. 
 Turnera ulmifolia or ‘chanana’ (Turneraceae) is a small herb with wide geographical 
distribution ranging from Guyana to the North Eastern region of Brazil. It is a widely 
used folk medicine for its anti-inflammatory properties. The hydroalcoholic extract of T. 
ulmifolia inhibited gastric lesions induced by pylorus ligature, by indomethacin and by 
ethanol, but stress mediated lesions remained unaffected. As histamine plays a role in 
ulcerogenesis in pylorus ligation, it was postulated by the study authors that T. ulmifolia 
exerts gastroprotective actions by inhibiting histamine. The inhibition of gastric ulcers 
induced by indomethacin and ethanol indicate that gastroprotective effects of T. 
ulmifolia could be due to an enhancement of mucosal defensive factors such as gastric 
mucus (Antônio & Souza Brito, 1998).  
 Dodonaea viscosa is a stiff bushy plant. Tribes who reside in the forest regions of South 
India (Kerala) use leaves of this plant for headaches and backaches. The hexane extract 
of Dodonaea viscosa dose dependently inhibited ethanol and indomethacin induced 
gastric lesions. Gastric secretion studies showed significant decrease of total acid in 
gastric juice (Arun & Asha, 2008). Furthermore, it decreased total acid content and 
increased gastric glutathione levels in ethanol and indomethacin treated rats.  
 Azadirachta indica is a native tree to the Indian subcontinent. To the Indian it is commonly 
known as Neem and regarded as a ‘village dispensary’ due its multiple therapeutic 
properties. It has been extensively used in Ayurveda, Siddha, Unani and other local 
Indian folklore medicine systems (Brahmachari, 2004). Standardized aqueous extract of 
Neem exhibited remarkable anti-ulcer activity in restraint-cold stress and indomethacin 
induced gastric ulcers in rats. Animal studies suggest that the major gastroprotective 
effect of Neem bark extract against ulcer is mediated through inhibition of acid 
secretion by H+-K+-ATPase and prevention of oxidative damage (Bandyopadhyay et 
al., 2002).  
 The aqueous extract of Neem bark when administered for 10 days at 30 mg dose twice 
daily significantly inhibited gastric acid secretion in patients with chronic gastric acid 
problem. The bark extract completely healed the duodenal ulcers at the dose of 30-60 mg 
twice daily for 10 weeks (Bandyopadhyay et al., 2004). Some important blood parameters 
for organ toxicity such as sugar, urea, creatinine, serum glutamate oxaloacetate 
transaminase, serum glutamate pyruvate transaminase, albumin, globulin, hemoglobin 
levels and erythrocyte sedimentation rate remained unaffected upon Neem exposure. 
 Pteleopsis suberosa is traditionally used in Mali for the treatment of gastric ulcers. The 
aqueous extract of P. suberosa exhibited protective effects on gastric mucosa in ethanol 
and indomethacin treated rats (De Pasquale et al., 1995). It has also been shown that 
Pteleopsis suberosa decoction containing triterpenoid saponins and tannins is effective 
against Helicobacter pylori (Germano` et al., 1998). 
 Calligonum comosum is a shrub distributed throughout Arabia and growing in sandy 
deserts. It is used by the local healers to treat stomach ailments. Pre-treatment with the 
10% ethanolic extract displayed a significant and dose-dependent inhibition of acute 
gastric ulcers induced by NSAIDs (phenylbutazone and indomethacin) and necrotic 
agents (0.2 N NaOH and 80% ethanol) (Liu et al., 2001). 
 Solanum torvum, a small tree, is widely used in African folk medicine to treat various 
diseases including gastric ulcer (Noumi et al., 2000). Aqueous and methanolic extracts from 
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leaves of Solanum torvum produced significant anti-ulcer activity in HCl/ethanol, 
indomethacin, pylorus ligation and cold-restraint stress induced gastric ulcers in rats. The 
authors proposed that the cytoprotective activity of extracts could be due to strengthening 
of the mucosal barrier through the increase of mucus production (Nguelefack et al., 2008).  
 Tetrapleura tetraptera and Guibourtia ehie Leonard are native trees to Ghana. The 
Ghanaian ethnomedical system employs these plant extracts in the management of 
stomach ulcers. In support of their traditional use, aqueous extracts of the barks of Tet. 
Tetraprera and G. ethie dose dependently inhibited HCl/ethanol induced gastric ulcers 
(Noamesi et al., 1994). 
 Glycyrrhiza glabra is a legume native to southern Europe and parts of Asia. It is a well-
known folk medicine for gastric ulcer (Aly et al., 2004). Gastric mucosal damage 
induced by NSAIDs is markedly reduced by G. glabra (Aly et al., 2004). Clinical data on 
Gycrrhiza glabra is inconsistent. In a double-blind clinical trial, administration of 
deglycyrrhizinized liquorice thrice daily at the dose of 760 mg for four weeks 
significantly accelerated the healing of gastric ulcer. In contrast, a cross over study at 
the same dose and treatment time reported no improvement in ulcer healing (Engqvist 
et al., 1973). A similar result was shown in a double-blind placebo- control study with 
administration of deglycyrrhizinized liquorice for one month at the dose of 380 mg 
thrice daily (Feldman et al., 1971). No side effects are reported in subjects who received 
deglycyrrhizinized liquorice extract in these studies.  
 
Plant 
Scientific 
Evidence 
Active Constituent(s) Reference 
Diodia sarmentosa Pre-clinical  Unknown Akah et al 
Cassia nigricans Pre-clinical Flavonoids Akah et al 
Ficus exasperate Pre-clinical Gallic acid & ellagic acid Akah et al ; Sirisha et 
al 
Synclisia scabrida Pre-clinical Alkaloids & flavonoids Akah et al ; Orisakwe 
et al ; Obi et al 
Eruca sativa Pre-clinical Flavonoids, sterols & 
triterpines 
Alqasoumi et al 
Turnera ulmifolia Pre-clinical Flavonoids Antônio et al 
Dodonaea viscosa Pre-clinical Flavonoids, saponins, bitter 
principles & phenols 
Arun et al 
Azadirachta indica  Pre-clinical & 
clinical 
Phenolic glycoside Bandyopadhyay et al 
Pteleopsis suberosa Pre-clinical Triterpenoid saponins & 
tannins 
De Pasquale et al ; 
Germanò et al 
Calligonum comosum Pre-clinical Unknown Liu et al 
Solanum torvum  Flavonoids, sterols & 
triterpenes 
Nguelefack et al 
Tetrapleura tetraptera Pre-clinical Unknown Noamesi et al 
Guibourtia ehie Pre-clinical Unknown Noamesi et al 
Glycyrrhiza glabra Pre-clinical & 
clinical 
Unknown Aly et al, Rees et al ; 
Engqvist et al; 
Feldman et al 
Table 1. Plants and their active constituents with anti-ulcer activity 
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3. Diarrhoea 
3.1 Experimental models 
Rodents are commonly used to induce experimental diarrhea and to study mechanisms of 
action of plants and their active principles. Castor oil, Prostaglandin E2 (PG-E2) and heat-labile 
enterotoxin are commonly used agents to induce diarrhea in animals. The diarrhoeal effect of 
castor oil is mediated through ricinoleic acid which causes irritation and inflammation of 
intestinal mucosa, and consequesntly leads to the stimulation of intestinal motility and 
increased secretion of fluid and electrolytes. This model is ideal to study the antisecretory and 
antimotility potential of medicinal plants. Prostaglandin E2 causes enteropooling by 
stimulating fluid secretion and increasing propulsive activity in the colon (Pierre et al., 1991). 
Heat-labile enterotoxin (LT) is the virulent factor of Escherichia coli and diarrhea by 
accumulation of salt and water in the intestinal lumen (Spangler., 1992). Therefore, the LT-
induced diarroheal model is suitable to study inhibitory effects of plant extracts on bacterial 
toxins. In addition, the charcoal meal test and charcoal-gum acacia-induced hyperperistalsis in 
animals are helpful to identity the effect of potential medicinal plants on intestinal motility.  
3.2 Plants tested for antidiarrheal activity in animal models of diarrhoea 
 Ficus bengalensis, Eugenia jambolana, Ficus racemosa and Leucas lavandulaefolia are 
commonly used folk medicine to treat diarrhoea by the people who live in Khatra 
region of West Bengal, India. Ethanolic exracts of Ficus bengalensis (hanging roots), 
Eugenia jambolana (bark), Ficus racemosa (bark) and Leucas lavandulaefolia (aerial parts) 
significantly inhibited castor oil induced diarrhoea and PGE2 induced enteropooling in 
rats. In addition, these extracts also showed a significant reduction in gastrointestinal 
motility in charcoal meal tests in rats (Mukherjee et al., 1997).  
 Geranium mexicanum plant is a commonly used medicinal plant in Traditional Mexican 
Medicine for the treatment of diarrhoea. Methanolic extract of Geranium mexicanum 
(roots) remarkably inhibited charcoal–gum acacia-induced hyperperistalsis in rats. 
However the authors suggested that this medicinal plant should be used with care to 
avoid toxic effects (Clazada et al., 2009).  
 Galla chinensis and Chaenomeles speciosa have been traditionally used in China to treat 
gastrointestinal disorders. These plant extracts significantly inhibited heat-labile 
enterotoxin-induced diarrhoea in the mouse (Chen et al., 2006, Chen et al., 2007). 
 Satureja hortensis is an annual herb that is traditionally used in Iran for treating stomach 
and intestinal disorders. Essential oil isolated from S. hortensis exhibited antispasmodic 
activity in isolated rat ileum. In addition, it also inhibited castor oil-induced diarrhea in 
mice (Hajhashemi et al., 1999).  
 Thespesia populnea, a large tree found in tropical regions and coastal forests of India, is 
traditionally used in India to treat several disorders including diarrhea and dysentery. 
Residue fraction of aqueous extract of T. populnea significantly inhibited castor oil and 
prostaglandin E2 (PGE2)-induced diarrhea induced diarrhea in rats. In addition, it also 
inhibited intestinal motility in the charcoal meal test (Viswanatha et al., 2011).  
 Mitragyna speciosa is an indigenous tree to Thailand, where it is commonly called 
kratom. In folk medicine, it is often used to treat diarrhea. Methanolic extract of M. 
speciosa dose dependently inhibited castor oil-induced diarrhea and intestinal transit in 
rats (Chittrakarn et al., 2008). 
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 Punica granatum is a deciduous shrub or small tree that is native to the Himalayas in 
north Pakistan and Northern India. Bark, rind of the fruit and seeds of this plant are 
used in folk medicine to treat diarrhea. Methanol extract of seeds of P. granatum dose 
dependently reduced castor oil induced diarrhea. It also significantly inhibited 
gastrointestinal motility and PGE2 mediated enteropooling in rats (Das et al., 1999). 
 
Plant 
Scientific 
Evidence 
Active Constituent(s) Reference 
    
Ficus bengalensis Pre-clinical  Tannin Mukherjee et al 
Eugenia jambolana Pre-clinical Tannin Mukherjee et al 
Ficus racemosa  Pre-clinical Tannin Mukherjee et al 
Leucas lavandulaefolia Pre-clinical Tannin Mukherjee et al 
Geranium mexicanum Pre-clinical (-)-epicatechin, tyramine Calzada et al 
Galla chinensis Pre-clinical Gallic acid Chen et al 
Chaenomeles speciosa Pre-clinical Oleanolic acid, ursolic acid & 
betulinic acid 
Chen et al 
Satureja hortensis Pre-clinical Carvacrol Hajhashemi et al 
Thespesia populnea Pre-clinical Unknown Viswanatha et al 
Mitragyna speciosa Pre-clinical Mitragynine & other alkaloids Chittrakarn et al 
Punica granatum Pre-clinical Tannin Das et al 
Table 2. Plants and their active constituent(s) with anti-diarrheal activity 
4. Inflammatory Bowel Diseases (IBD) 
4.1 Animal models of IBD 
In IBD oxidative stress mediates disease progression by disrupting epithelial cell integrity. 
Acetic acid-induced colitis is helpful to screen herbs which can inhibit cytotoxic effects of 
reactive oxygen species (ROS). Dextran sulphate sodium (DSS)-induced colitis is also a 
frequently used animal colitis model in ethnopharmacological studies. This model is useful 
to test the effect of herbs on inflammatory cytokines mediated cellular injury (Dieleman et 
al., 1998). The transgenic rat model (HLA-B27) with overt chronic gastrointestinal tract 
inflammation also serves to screen medicinal herbs to treat IBD.  
 Zingiber officinale is traditionally used to treat inflammatory gastrointestinal disorders. 
Ethanolic extract of dried rhizomes of ginger displayed protective effects against acetic 
acid-induced ulcerative colitis in rats (El-Abhar et al., 2008).  
 Cordia dichotoma is a deciduous tree with many medicinal uses in Ayurveda. 
Traditionally bark of the plant is reported for the treatment of ulcerative colitis. 
Methanolic extract of C. Dichotoma improved lesions and reduced colonic 
myeloperoxidase (MPO) and malondialdehyde (MDA) in acetic acid induced UC in 
male swiss mice (Ganjare et al., 2011).  
 Patrinia scabiosaefolia is a commonly used herbal medicine in Korea. It is used 
traditionally to treat colonic inflammations. Methanolic extract of P. Scabiosaefolia 
significantly attenuated dextran sulfate sodium induced colitis in mice. In addition, it 
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also suppressed colonic MPO accumulation and pro-inflammatory mediators (TNFα, 
IL-1, IL-6 and nitric oxide) (Cho et al., 2011).  
 Vitex negundo is a shrub that grows in Southeast Asia. Traditionally its roots are used in 
the treatment of ulcerative colitis in India. Ethanolic extract of V. negrundo significantly 
inhibited acetic acid ulcerative colitis and reduced colonic MPO and MDA levels in 
mice (Zaware et al., 2011). 
 Pistacia lentiscus is a dioecious shrub that grows in the Mediterranean region. Oleogum 
resin from P. Lentiscus is used in traditional Iranian medicine to treat IBD. Treatment 
with oleogum resin from P. Lentiscus improved the symptoms of dextran sulfate 
sodium (DSS) induced colitis in mice (Kim & Neophytou, 2009). A pilot study 
conducted in mild to moderate Crohn’s disease patients demonstrated that mastic 
(resin) from P. Lentiscus significantly reduced disease activity index, plasma IL-6 and C-
reactive protein (Kaliora et al., 2007a) and TNFα in peripheral blood mononuclear cells 
(Kaliora et al., 2007b). In addition, total antioxidant potential was significantly 
increased. No side effects are observed in mastic treated patients (Kaliora et al., 2007a). 
A double-blind clinical trial in patients with duodenal ulcers exhibited symptomatic 
relief in 80% patients on mastic and 50% patients on placebo, while endoscopically 
proven healing occurred in 70% patients on mastic (Al-Habbal et al., 1984). 
 Plantago ovata is a well-known medicinal plant in the treatment of IBD. P. ovate seeds 
ameliorated the development of colonic inflammation in transgenic rats as evidenced 
by an improvement of intestinal cytoarchitecture, significant decrease in some of the 
pro-inflammatory mediators and higher production of short-chain fatty acids 
(Rodrı́guez-Cabezas et al., 2003). An open label, parallel-group, multicenter, 
randomized clinical trial in patients with ulcerative colitis concluded that Plantago ovata 
seeds (dietary fiber) might be as effective as mesalamine to maintain remission in 
ulcerative colitis (Ferna´ndez-Ban˜ ares et al., 1999). 
 Boswellia serrata, a tree which grows in the hilly areas of India, is an efficacious remedy 
for IBD in traditional Iranian medicine and also it has been used in the Ayurvedic 
medicine for the treatment of inflammatory diseases. Despite its traditional claims, 
Boswellia extracts are ineffective in ameliorating colitis in DSS-induced colitis in mice 
(Kiela et al., 2004). In contrast to animal studies, a double-blind, randomized, placebo-
controlled, multicenter trial in colitis patients showed higher remission in Boswellia 
serrata extract treated group than in the pacebo group (Madisch et al., 2007). However, 
a recent double-blind, placebo-controlled, randomized, parallel study in patients with 
Crohn's disease has shown no difference between the Boswellia treated group and 
control group in disease remission (Holtmeier et al., 2011).  
5. Quality, efficacy and safety of herbal medicines 
5.1 Quality 
The quality of herbal medicines is important to ensure their safe use and efficacy. In contrast 
to well characterized conventional medicine, assurance of the quality of herbal medicine is a 
major concern. The problems associated with the herbal products include deliberate or 
accidental inclusion of prohibited or restricted ingredients, substitution or adulteration of 
herbal materials, contamination with toxic substances and differences between labelled and 
actual contents (Barnes et al., 2nd ed). However, increased consumer awareness and  
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Plant 
Scientific 
Evidence 
Chemical Constituents Reference 
    
Zingiber officinale Pre-clinical Gingerols El-Abhar et al ; 
Minaiyan et al 
Cordia dichotoma Pre-clinical Apigenin Ganjare et al 
Patrinia scabiosaefolia Pre-clinical Oleanonic acid, oleanolic acid 
&  
ursolic acid  
Cho et al 
Vitex negundo Pre-clinical Unknown Zaware et al 
Pistacia lentiscus Pre-clinical & 
clinical 
Oleanolic acid Kim et al; Kaliora et 
al; Al-Habbal 
Plantago ovata Pre-clinical & 
clinical 
Unknown Rodriguez-Cabezas 
et al ; Fernandez-
Banares et al  
Boswellia serrata Pre-clinical & 
clinical 
Boswellia acids Kiela et al ; 
Madisch et al ; 
Holtmeier et al 
Table 3. Plants and their active constituents for treatment of ulcerative colitis/IBD 
regulatory agencies’ strict guidelines on the quality and stability of herbal products has led 
to significant improvements in the quality control of herbal medicines. Recently the herbal 
manufacturing industry has focused on improving its quality assurance and quality control 
mechanisms to guard against the frequent episodes of substandard quality and possible 
adulterations. Use of high-performance liquid chromatograms, thin-layer chromatography, 
atomic absorption spectroscopy, gas chromatography and where necessary more 
sophisticated techniques such as NMR and LC/MS has now become common in 
complementary medicines manufacturing industries to ensure the quality of plant materials 
and final product (Rosenbloom et al., 2011). The emphasis on good manufacturing practice 
has steadily increased over years. In addition, new regulatory laws are now in place on 
product stability to support its shelf life. With the steady progress on different herbal quality 
control fronts, it is now possible to apply almost the same set of quality standards as for 
conventional medicines. As most of the traditional herbs listed in this chapter are not 
commercially manufactured, the data on the quality of these plant medicines is scarce.  
5.2 Efficacy 
Herbal medicines have a long history of traditional use. However, from today’s stand point, 
traditional claims need to be verified. A well-designed randomized controlled trial is 
essential to determine the efficacy and safety of herbal medicines. The use of standardized 
herbal extracts in clinical trials is important to obtain reproducible data on the efficacy and 
safety of herbal medicines. Standardization of herbal extracts has become a common 
practice in phytomedicines. It allows the establishment of reproducible pharmaceutical 
quality by comparing a product with established reference substances and by defining the 
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specific quantity of one or several compounds. As the herbs are of natural origin, their 
chemical composition is affected by several factors (climate, growing conditions, time of 
harvesting, storage conditions and processing). Therefore, the use of standardized herbal 
extracts in preclinical and clinical research is helpful to develop evidence based traditional 
therapies. Although rigorous clinical investigations are lacking at present for many herbs 
used in GIT disorders, there is a vast literature on the in vitro and in vivo pharmacological 
effects of medicinal plants. These pre-clinical observations provide a rationale for further 
investigation of such plants. 
5.3 Safety 
The positive attitude towards herbal medicines is based on the testimony that herbs have 
been used since antiquity and the belief that they have the advantage of being ‘natural’ 
rather than ‘synthetic’. Traditional healing systems employed herbal medicines for the 
symptomatic management of diseases. However, these herbs are now being used 
extensively for health promotion and disease prevention not only in underdeveloped and 
developing nations, but also increasingly in developed nations. As little is known regarding 
adverse effects of herbal medicines and their frequencies, the chronic exposure of these 
herbal ingredients may pose health risks. In particular, when herbs are extracted and 
purified, their toxicity might be increased due to increased concentration of potential toxic 
compounds. Therefore, the common assumption that herbal medicines are by inference 
‘safe’ may not be valid by today’s health standards. 
Generally, traditional herbal medicines lack the following pharmacological data in humans:  
 pharmacologically active chemical constituents and their metabolites 
 mechanisms of action of active constituents/whole extract 
 pharmacokinetics 
 toxicology 
 adverse effects and their frequencies 
 drug–herb and food–herb interactions 
 use in vulnerable individuals: children, elderly, individuals with renal or hepatic 
disease, gender effects, individuals with a different genetic profile 
 contraindications  
Phytochemical and pharmacological (preclinical and clinical) studies are important to address 
the above issues. The majority of the herbs mentioned in this chapter are tested only in 
animals. The main focus of these studies has been determining the efficacy of herbal extracts to 
support their traditional claims. However, it is a common procedure in these animal studies to 
measure toxic dose of herbal extracts. These toxicological studies are important to provide in 
vivo data in a whole animal situation on the dose and adverse effects of herbal extracts which 
may be relevant when tested in humans. None of these studies have reported any major 
adverse events in the experimental models of various GI disorders.  
6. Conclusion 
The use of plants in treating diseases is a very old human tradition. This knowledge, derived 
from observations and experiences, has been handed over from generation to generation 
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verbally and also in the form of ancient texts. Medicinal plants are the foundations for 
modern therapeutic agents. Herbal medicines are an important part of the health care 
system in many developing countries. The use of herbal medicines, as health promoting 
agents, in developed countries has also increased and this trend is continuing. Healthcare 
professionals need to be aware of the pharmacology of these herbal medicines in order to 
provide well informed advice to patients. The traditional herbal medicines field is very vast. 
In this chapter we attempted to provide scientific evidence for the herbs with historical use 
in three major GIT disorders namely: peptic ulcer, diarrhoea and IBD. Researchers 
successfully reproduced these human disorders in animals by employing a range of 
chemical agents and scientific procedures. In some cases, these models not only have 
supported the traditional claims, but also provided important information on the 
mechanism of action of the plant extracts and in some cases their components. The majority 
of these preclinical studies established the scientific evidence to traditional herbal medicines. 
Unfortunately, very few clinical trials are conducted to translate animal data into humans. 
As clinical trials are important to furnish efficacy and safety data, the lack of clinical data 
has become the main impediment in developing traditional herbal remedies into 
mainstream medicines. Recent progress in the quality control of herbal products is very 
promising in gaining consumer confidence and promoting consideration of herbal 
medicines as complementary and in some cases alternative approaches to conventional 
therapies. Medicinal plants listed in this chapter have the potential to treat peptic ulcer, 
diarrhoea and IBD. Additional studies on quality, efficacy and safety in animals and 
humans will be required to integrate them in mainstream medicine. 
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